Drank-like to make one comment regarding NWBO. Their vaccine is safe and no death has reported. Others do not have similar vaccine as u said. Others fail therefore makes NWBO much bigger player and valuable. Per latest account from insiders many people are living longer than SOC treatment. Unfortunately the company had to extend the phase 3 by couple of more years to prove that. We will see in a month or 2 the efficiency of their drug.

Now back to ipix and NBY. Market cap at this moment is meaningless. You have to look at what is market penetration for anti- bacterial eye wash and determine the market cap for NBY. If they have say $30m sales then market cap should be around $150 mil. I am just throwing numbers here.

Ipix has two great products. But one thing is going against them is financials. Basically no money to do phase 3. Big pharma knows this and they will do everything to take advantage of this issue. Question is does Leo have plan to counter this or not.